13F-HR filed by Deep Track Capital, LP
Deep Track Capital, LP filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 66 holding rows worth $3,491,094,084.
- Accession
- 0001856083-24-000002
- Filer
- CIK 1856083
- Filed
- 2024-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 66 entries on the cover page, a total value of $3,491,094,084 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,491,094,084 with VALUE read as dollars as filed, 13F file number 028-21949. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 3,479,853 | $171,278,365 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 550,000 | $156,376,000 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 2,323,456 | $154,393,651 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 4,783,679 | $129,781,211 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 4,555,383 | $129,327,323 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 832,310 | $124,388,730 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 6,000,000 | $123,780,000 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 300,000 | $118,116,000 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 4,210,784 | $115,838,668 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 12,721,460 | $115,765,286 | dollars as filed | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 9,141,660 | $113,448,001 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 1,304,721 | $104,116,736 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 1,500,000 | $103,800,000 | dollars as filed | |
| GERON CORP | 374163103 | COM | 30,505,929 | $100,669,566 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 15,272,172 | $97,436,457 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 3,034,453 | $96,677,673 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 3,500,000 | $94,745,000 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 3,490,506 | $86,913,599 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 5,750,000 | $85,675,000 | dollars as filed | |
| MIND MEDICINE MINDMED INC | 60255C885 | COM NEW | 6,666,667 | $62,666,670 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 4,297,438 | $61,453,363 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 3,456,053 | $60,515,488 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 1,373,475 | $59,540,141 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 1,000,000 | $58,780,000 | dollars as filed | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 822,001 | $56,824,929 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 7,370,000 | $56,822,700 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 3,187,415 | $51,285,507 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 1,262,246 | $50,742,289 | dollars as filed | |
| INVIVYD INC | 00534A102 | COMMON STOCK | 10,953,937 | $48,635,480 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 1,213,420 | $46,025,021 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 2,997,830 | $44,068,101 | dollars as filed | |
| HILLEVAX INC | 43157M102 | COM | 2,572,460 | $42,780,010 | dollars as filed | |
| EDITAS MEDICINE INC | 28106W103 | COM | 5,527,290 | $41,012,492 | dollars as filed | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 5,572,607 | $40,902,935 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 6,100,000 | $40,016,000 | dollars as filed | |
| ENGENE HOLDINGS INC | 29286M105 | COM | 2,250,000 | $38,137,500 | dollars as filed | |
| Tourmaline Bio Inc | 89157D105 | Common Stock | 1,595,400 | $36,534,660 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 3,225,419 | $36,511,743 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 1,643,881 | $35,507,830 | dollars as filed | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 7,000,000 | $26,250,000 | dollars as filed | |
| CYBIN INC | 23256X100 | COM | 58,139,535 | $24,040,698 | dollars as filed | |
| ALECTOR INC | 014442107 | COMMON STOCK | 3,769,386 | $22,691,704 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 274,512 | $20,613,106 | dollars as filed | |
| AGENUS INC | 00847G705 | COM NEW | 31,697,539 | $18,384,573 | dollars as filed | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 4,184,100 | $17,824,266 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 18,400,000 | $17,189,280 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 493,352 | $15,940,203 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 1,000,000 | $13,750,000 | dollars as filed | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 2,684,344 | $12,643,260 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 175,400 | $12,137,680 | dollars as filed | put |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 680,000 | $12,076,800 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 529,452 | $11,923,259 | dollars as filed | |
| REGULUS THERAPEUTICS INC | 75915K309 | COM | 3,266,566 | $9,407,710 | dollars as filed | |
| ALTO NEUROSCIENCE INC COM SHS | 02157Q109 | Stock | 600,000 | $9,210,000 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 167,784 | $7,833,835 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 2,523,000 | $6,484,110 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 5,000,000 | $6,300,000 | dollars as filed | |
| ALIGOS THERAPEUTICS INC COM NEW | 01626L105 | Stock | 6,102,770 | $5,980,715 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 1,240,034 | $5,766,158 | dollars as filed | |
| VIGIL NEUROSCIENCE INC | 92673K108 | COM | 1,594,931 | $5,438,715 | dollars as filed | |
| METAGENOMI THERAPEUTICS INC | 59102M104 | COM | 466,232 | $4,918,748 | dollars as filed | |
| SYROS PHARMACEUTICALS INC | 87184Q206 | COM NEW | 828,485 | $4,432,395 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 579,674 | $2,596,940 | dollars as filed | |
| PRIME MEDICINE INC | 74168J101 | COM | 303,716 | $2,126,012 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 316,000 | $2,123,520 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 40,137 | $1,720,272 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001856083-24-000002 | this filing | 2024-05-15 | acceptance time not in the bulk data set |